| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
HLB bioStep Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩3,715.00 |
| 52 Week High | ₩5,120.00 |
| 52 Week Low | ₩2,430.00 |
| Beta | 0.47 |
| 1 Month Change | -2.88% |
| 3 Month Change | 31.27% |
| 1 Year Change | -25.55% |
| 3 Year Change | 23.38% |
| 5 Year Change | n/a |
| Change since IPO | -8.40% |
Recent News & Updates
Subdued Growth No Barrier To HLB bioStep Co.,Ltd. (KOSDAQ:278650) With Shares Advancing 29%
Mar 29
Here's Why HLB bioStepLtd (KOSDAQ:278650) Has A Meaningful Debt Burden
Feb 28Recent updates
Subdued Growth No Barrier To HLB bioStep Co.,Ltd. (KOSDAQ:278650) With Shares Advancing 29%
Mar 29Here's Why HLB bioStepLtd (KOSDAQ:278650) Has A Meaningful Debt Burden
Feb 28With EPS Growth And More, KNOTUSLtd (KOSDAQ:278650) Is Interesting
Mar 17What Kind Of Investors Own Most Of KNOTUS Co.,Ltd (KOSDAQ:278650)?
Feb 24Is KNOTUSLtd (KOSDAQ:278650) Using Too Much Debt?
Feb 03
Investors Who Bought KNOTUSLtd (KOSDAQ:278650) Shares A Year Ago Are Now Up 26%
Jan 13Should We Be Delighted With KNOTUS Co.,Ltd's (KOSDAQ:278650) ROE Of 15%?
Dec 23Is Now The Time To Put KNOTUSLtd (KOSDAQ:278650) On Your Watchlist?
Dec 02Shareholder Returns
| A278650 | KR Life Sciences | KR Market | |
|---|---|---|---|
| 7D | -3.0% | -3.7% | -4.3% |
| 1Y | -25.6% | -1.3% | -1.0% |
Return vs Industry: A278650 underperformed the KR Life Sciences industry which returned -0.4% over the past year.
Return vs Market: A278650 underperformed the KR Market which returned 0.6% over the past year.
Price Volatility
| A278650 volatility | |
|---|---|
| A278650 Average Weekly Movement | 11.5% |
| Life Sciences Industry Average Movement | 7.5% |
| Market Average Movement | 5.2% |
| 10% most volatile stocks in KR Market | 12.0% |
| 10% least volatile stocks in KR Market | 2.4% |
Stable Share Price: A278650 has not had significant price volatility in the past 3 months.
Volatility Over Time: A278650's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of KR stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2012 | 161 | In-Sung Jeong | www.knotus.co.kr |
HLB bioStep Co.,Ltd. provides various test services. It offers platform technology services, such as cell-enzyme-based screening, xenograft assay, mitogenic effect test, vaccine antigen, antibody titration, cytokine, MRNA expression, trachea relaxation assay, carrageenan, adjuvant induced paw edema, antipyretic, anti-pain test, isolated blood vessel screening, fibrin plate lysis screening, ferric chloride induced model, food diet induced model, gastric acid secretion, emesis model, MIC test, post antibody effect, enzyme assay, systemic, local infection model, PK study, chemical, transgenic animal, osteoblast-like cell line screening, bone formation marker, and biomarker.
HLB bioStep Co.,Ltd. Fundamentals Summary
| A278650 fundamental statistics | |
|---|---|
| Market cap | ₩317.76b |
| Earnings (TTM) | -₩164.04m |
| Revenue (TTM) | ₩52.81b |
6.0x
P/S Ratio-1,937x
P/E RatioIs A278650 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A278650 income statement (TTM) | |
|---|---|
| Revenue | ₩52.81b |
| Cost of Revenue | ₩16.79b |
| Gross Profit | ₩36.02b |
| Other Expenses | ₩36.19b |
| Earnings | -₩164.04m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.92 |
| Gross Margin | 68.21% |
| Net Profit Margin | -0.31% |
| Debt/Equity Ratio | 57.7% |
How did A278650 perform over the long term?
See historical performance and comparison